Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence

AI-driven [<sup>99m</sup>Tc]Tc-DPD SPECT/CT analysis effectively detects treatment-induced reductions in cardiac amyloid burden, offering a non-invasive biomarker for early response assessment in ATTR-CM. AI-enabled imaging markers enhance reproducibility and efficiency, providing valuable support for personalized treatment strategies as new therapeutic options for ATTR-CM become available.

Authors

Institutions

Publication Details

Journal
European Journal of Nuclear Medicine and Molecular Imaging
Published
2025-11-29
DOI
https://doi.org/10.1007/s00259-025-07673-6
Citations
1
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence

Christian Hengstenberg, Michaela Auer‐Grumbach, Clemens P. Spielvogel, Jing Ning et al.
1 citations
European Journal of Nuclear Medicine and Molecular Imaging
Amyloidosis: Diagnosis, Treatment, Outcomes
0.81
article

Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence

Christian Hengstenberg, Michaela Auer‐Grumbach, Clemens P. Spielvogel, Jing Ning, Josef Yu, Raffaella Calabretta, Nikita Ermolaev, Roza Badr Eslam, David Kersting, Johannes Kästner, Franz Duca, Markus Köfler, Christina Binder, Michael Poledniczek, Jutta K Bergler-Klein, Christina Kronberger, René Rettl, Andreas Anselm Kammerlander, Zewen Jiang, David Haberl, Christian Nitsche, Marcus Hacker, Lena Marie Schmid
article en
1 citations

Abstract

AI-driven [<sup>99m</sup>Tc]Tc-DPD SPECT/CT analysis effectively detects treatment-induced reductions in cardiac amyloid burden, offering a non-invasive biomarker for early response assessment in ATTR-CM. AI-enabled imaging markers enhance reproducibility and efficiency, providing valuable support for personalized treatment strategies as new therapeutic options for ATTR-CM become available.

European Journal of Nuclear Medicine and Molecular ImagingVol. 53(5)
Austrian Research Institute for Artificial Intelligence (AT), Essen University Hospital (DE), University of Duisburg-Essen (DE), Medical University of Vienna (AT)
Universität Wien, Medizinische Universität Wien
Openalex Percentile: Top 21%
Amyloidosis: Diagnosis, Treatment, Outcomes
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.